CA
NZ
UK
AU
IND
US
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a 5.34% beneficial ownership position in Avidbank Holdings, Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a beneficial ownership position in B&R Technology Merger Corp. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC disclosing beneficial ownership of 4,066,391 shares of Perella Weinberg Partners Class A Common Stock, with a triggering event date of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares of Bleichroeder Acquisition Corp. III as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed an amended Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Common Shares of Helus Pharma Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed Amendment No. 2 to Schedule 13G with the SEC on November 12, 2026, disclosing a 2.26% beneficial ownership position in Tenax Therapeutics, Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing beneficial ownership of Class A Ordinary Shares in Viking Acquisition Corp. II as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G on November 12, 2026, disclosing beneficial ownership of 1,800,000 Class A Ordinary Shares of Columbus Circle Capital Corp III as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a 5.81% beneficial ownership position in First Tracks Biotherapeutics, Inc. as of September 30, 2026.
Adage Capital Management, L.P., along with managing members Robert Atchinson and Phillip Gross, filed a Schedule 13G with the SEC on November 12, 2026, disclosing a beneficial ownership position in Freedom Metals Acquisition Corp. as of September 30, 2026.
Please wait processing your request...